Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism

Journal of Surgical Research

Volumn 66, Issue 1, 1996, Pages 36-42

  Welling, Theodore H ^a   Huber, Thomas S ^a   Messina, Louis M ^a   Stanley, James C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; LAVENDUSTIN A; PLASMIN; PROTEIN TYROSINE KINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DOG; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0030293690     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0369     Document Type: Article

References (50)

1. 1. Vlodavsky, I. G., Korner, R., Ishai-Michaeli, P., Bashkin, R., Bar-Shavit, R., and Fuks, Z. Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 9: 203, 1990.
2. 2. Bachmann, F., and Kruithof, I. K. O. Tissue plasminogen activator: Chemical and physiological aspects. Semin. Thromb. Hemo. 10: 6, 1984.
3. 3. Hudlicka, O., and Tyler, K. R. Angiogenesis London: Academic Press, 1986, p. 221.
4. 4. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., Shriver, L., Dan, K., and Grndahl-Hansen, J. Plasminogen activators, tissue degredation, and cancer. Adv. Cancer Res. 44: 139, 1985.
5. 5. Banyai, L., Varadi, A., and Patthy, L. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Lett. 163: 37, 1983.
6. 6. Hajjar, K. A., Hamel, N. M., Harpel, P. C., and Nachman, R. L. Binding of tissue plasminogen activator to cultured human endothelial cells. J. Clin. Invest. 80: 1712, 1987.
7. 7. Beebe, D. P., Miles, L. A., and Plow, E. F. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 74: 2034, 1989.
8. 8. Hajjar, K. A. The endothelial cell tissue plasminogen activator receptor. J. Biol. Chem. 266: 21962, 1991.
9. 9. Hajjar, K. A., and Hamel, N. M. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J. Biol. Chem. 265: 2908, 1990.
10. 10. Bassel-Duby, R., Jiang, N., Bittick, T., Madison, E., McGookey, D., Orth, K., Shohet, R., Sambrook, J., and Gething, M. Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor. J. Biol. Chem. 267: 9668, 1992.
11. 11. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 43: 175, 1985.
12. 12. Grondahl-Hansen, J., Bach, F., Munkholm-Larsen, P., and Grndahl-Hansen, J. Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay. Br. J. Cancer 61: 412, 1990.
13. 13. Rella, C., Coviello, M., Quaranta, M., and Paradiso, A. Tissue-type plasminogen activator as marker of functional steroid receptors in human breast cancer. Thromb. Res. 69: 209, 1993.
14. 14. Pollack, R., Risser, R., Conlon, S., and Rifkin, D. Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cell by simian virus 40. Proc. Natl. Acad. Sci. USA 71: 4792, 1974.
15. 15. Jankun, J., Maher, V. M., and McCormick, J. J. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator. Cancer Res. 51: 1221, 1991.
16. 16. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Ins. 84: 1875, 1992.
17. 17. Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120, 1992.
18. 18. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324: 1, 1991.
19. 19. Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., and Schweigerer, L. The endogenous metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368: 237, 1994.
20. 20. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58, 1989.
21. 21. Blood, C. H., and Zetter, B. R. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim. Biophys. Acta. Rev. Cancer 1032: 89, 1990.
22. 22. Klagsbrun, M., and Folkman, J. Peptide Growth Factors and Their Receptors II. Berlin: Springer, 1990. Pp. 549-586.
23. 23. Takahashi, K., Mulliken, J. B., Kozakewich, H. P. W., Rogers, R. A., Folkman, J., and Ezekowitz, R. A. B. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 93: 2357, 1994.
24. 24. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science 235: 442, 1987.
25. 25. Mawatari, M., Okamura, K., Matsuda, T., Hamanaka, R., Mizoguchi, H., Higashio, K., Kohno, K., and Kuwano, M. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp. Cell Res. 192: 574, 1991.
26. 26. Yasunaga, C., Nakashima, Y., and Sueishi, K. A role of fibrinolytic activity in angiogenesis. Lab. Invest. 61: 698, 1989.
27. 27. Laiho, M., and Keski-Oja, J. Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res. 49: 2533, 1989.
28. 28. Montesano, R., and Orci, L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42: 469, 1985.
29. 29. Quigley, J. P. Phorbol ester-induced morphological changes in transformed chick fibroblasts: Evidence for direct catalytic involvement of plasminogen activator. Cell 17: 131, 1979.
30. 30. Gyetko, M. R., Todd, R. F., III, Wilkinson, C. C., and Sitrin, R. G. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93: 1380, 1994.
31. 31. Wainberg, M. A., Israel, E., and Margolese, R. G. Further studies on the mitogenic and immune-modulating effects of plasminogen activator. Immunology 45: 715, 1982.
32. 32. Nusrat, A. R., and Chapman, H. A., Jr. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87: 1091, 1991.
33. 33. Ford, J. W., Burkel, W. E., and Kahn, R. H. Isolation of adult canine venous endothelium for tissue culture. In Vitro 17: 44, 1981.
34. 34. Voyta, J. C., Via, D. P., Butterfield, C. E., and Zetter, B. R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99: 2034, 1984.
35. 35. Heussen, C., Joubert, F., and Dowdle, E. B. Purification of human tissue plasminogen activator with erythrina trypsin inhibitor. J. Biol. Chem. 259: 11635, 1984.
36. 36. Hsu, C. J., Persons, P. E., Spada, A. P., Bednar, R. A., Levitzki, A., and Zilberstein, A. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by lavendustin-A and its analogue. J. Biol. Chem. 266: 21105, 1991.
37. 37. Yamane, H. K., and Fung, B. K. K. Covalent modifications of G-proteins. Annu. Rev. Pharmacol. Toxicol. 32: 201, 1993.
38. 38. Rothermel, J. D., and Botelho, L. H. P. A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem. J. 251: 757, 1988.
39. 39. Silverstein, R. L., Leung, L. L. K., Harpel, P. C., and Nachman, R. L. Complex formation of platelet thrombospondin with plasminogen: Modulation of activation by tissue activator. J. Clin. Invest. 74: 1625, 1984.
40. 40. van Zonneveld, A., Veerman, H., and Pannekoek, H. Autonomous functions of structural domains on human tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 83: 4670, 1986.
41. 41. Devore, J. L. Probability and Statistics for Engineering and the Sciences. Belmont, CA: Brooks/Cole, 1991. Pp. 337-355, 372-386.
42. 42. Hotchkiss, A., Refino, C. J., Leonard, C. K., O'Connor, J. V., Crowley, C., McCabe, J., Tate, K., Nakamura, G., Powers, D., Levinson, A., Mohler, M., and Spellman, M. W. The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator. Thromb. Haemostasis 60: 255, 1988.
43. 43. Barnathan, E. S., Kuo, A., Van der Keyl, H., McCrae, K. R., Larsen, G. R., and Cines, D. B. Tissue-type plasminogen activator binding to human endothelial cells. J. Biol. Chem. 263: 7792, 1988.
44. 44. Wing, L. R., Bennett, B., and Booth, N. A. The receptor for tissue plasminogen activator (t-PA) in complex with its inhibitor, PAI-1, on human hepatocytes. FEBS Lett. 278: 95, 1991.
45. 45. Larsen, G. R., Henson, K., and Blue, Y. Variants of human tissue-type plasminogen activator. J. Biol. Chem. 263: 1023, 1988.
46. 46. Saksela, O., Moscatelli, D., and Rifkin, D. B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J. Cell Biol. 105: 957, 1987.
47. 47. Pepper, M. S., Belin, D., Montesano, R., Orci, L., and Vassalli, J. D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111: 743, 1990.
48. 48. Vu, T. K., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057, 1991.
49. 49. Castellot, J. J., Jr., Kambe, A. M., Dobson, D. E., and Spiegelman, B. M. Heparin potentiation of 3T3-adipocyte stimulated angiogenesis: Mechanisms of action on endothelial cells. J. Cell Phys. 127: 323, 1986.
50. 50. Gerard, R. D., and Meidell, R. S. Regulation of tissue plasminogen activator expression. Annu. Rev. Physiol. 51: 245, 1989.